The microbiome and atopic eczema: More than skin deep

Australasian Journal of Dermatology

Volumn 58, Issue 1, 2017, Pages 18-24

  Thomas, Charlotte L ^a   Fernández Peñas, Pablo ^a  

^a SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

Author keywords

16s rRNA; atopic dermatitis; atopic eczema; atopy; gut; hygiene hypothesis; lung; microbiome; probiotic; Staphylococcus aureus

Indexed keywords

HYPOCHLORITE SODIUM; PROBIOTIC AGENT; PSEUDOMONIC ACID; STEROID;

ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; DISEASE EXACERBATION; FUNGUS IDENTIFICATION; HUMAN; IMMUNE SYSTEM; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; PATHOPHYSIOLOGY; POPULATION ABUNDANCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN FLORA; SPECIES HABITAT; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; TREATMENT RESPONSE; INTESTINE FLORA; MICROBIOLOGY; MICROFLORA; RECURRENT DISEASE; RESPIRATORY SYSTEM; SKIN;

DERMATITIS, ATOPIC; GASTROINTESTINAL MICROBIOME; HUMANS; MICROBIOTA; PROBIOTICS; RESPIRATORY SYSTEM; SKIN; STAPHYLOCOCCUS AUREUS; SYMPTOM FLARE UP;

EID: 85012202851     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/ajd.12435     Document Type: Review

References (54)

1. Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell. Immunol. 2014; 5: 202.
2. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014; 69: 3–16.
3. Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J. Am. Acad. Dermatol. 1986; 15: 487–94.
4. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151–60.
5. Beck LA, Thaci D, Hamilton JD et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N. Engl. J. Med. 2014; 371: 130–9.
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006; 38: 441–6.
7. Wang LF, Lin JY, Hsieh KH et al. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J. Immunol. 1996; 156: 4077–82.
8. Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 2009; 124: R7–12.
9. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259–60.
10. Adlerberth I, Strachan DP, Matricardi PM et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J. Allergy Clin. Immunol. 2007; 120: 343–50.
11. Findley K, Grice EA. The skin microbiome: a focus on pathogens and their association with skin disease. PLoS Pathog. 2014; 10: e1004436.
12. Grice EA. The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease. Semin. Cutan. Med. Surg. 2014; 33: 98–103.
13. Hannigan GD, Grice EA. Microbial ecology of the skin in the era of metagenomics and molecular microbiology. Cold Spring Harb. Perspect. Med. 2013; 3: a015362.
14. Kong HH, Segre JA. Skin microbiome: looking back to move forward. J. Invest. Dermatol. 2012; 132: 933–9.
15. Chen YE, Tsao H. The skin microbiome: current perspectives and future challenges. J. Am. Acad. Dermatol. 2013; 69: 143–55.
16. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207–14.
17. Staley JT, Konopka A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu. Rev. Microbiol. 1985; 39: 321–46.
18. Fredricks DN. Microbial ecology of human skin in health and disease. J. Investig. Dermatol. Symp. Proc. 2001; 6: 167–9.
19. Grice EA, Kong HH, Conlan S et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324: 1190–2.
20. Fierer N, Hamady M, Lauber CL et al. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc. Natl Acad. Sci. U.S.A. 2008; 105: 17994–9.
21. Dekio I, Sakamoto M, Hayashi H et al. Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis. J. Med. Microbiol. 2007; 56: 1675–83.
22. Findley K, Oh J, Yang J et al. Topographic diversity of fungal and bacterial communities in human skin. Nature 2013; 498: 367–70.
23. Dominguez-Bello MG, Costello EK, Contreras M et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. U.S.A. 2010; 107: 11971–5.
24. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 1974; 90: 525–30.
25. Gong JQ, Lin L, Lin T et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br. J. Dermatol. 2006; 155: 680–7.
26. Huang JT, Abrams M, Tlougan B et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123: e808–14.
27. Akiyama H, Toi Y, Kanzaki H et al. Prevalence of producers of enterotoxins and toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions. Arch. Dermatol. Res. 1996; 288: 418–20.
28. Akdis M, Simon HU, Weigl L et al. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J. Immunol. 1999; 163: 466–75.
29. Sugita T, Takashima M, Shinoda T et al. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J. Clin. Microbiol. 2002; 40: 1363–7.
30. Oh J, Freeman AF, Park M et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res. 2013; 23: 2103–14.
31. Iwase T, Uehara Y, Shinji H et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 2010; 465: 346–9.
32. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J. Invest. Dermatol. 2011; 131: 1974–80.
33. Kong HH, Oh J, Deming C et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012; 22: 850–9.
34. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837–48.
35. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. U.S.A. 2010; 107: 14691–6.
36. Watanabe S, Narisawa Y, Arase S et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J. Allergy Clin. Immunol. 2003; 111: 587–91.
37. Kalliomaki M, Kirjavainen P, Eerola E et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001; 107: 129–34.
38. Penders J, Thijs C, van den Brandt PA et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study. Gut 2007; 56: 661–7.
39. Ismail IH, Oppedisano F, Joseph SJ et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr. Allergy Immunol. 2012; 23: 674–81.
40. Abrahamsson TR, Jakobsson HE, Andersson AF et al. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 2012; 129: 434–40, 40 e1–2.
41. Penders J, Stobberingh EE, Thijs C et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin. Exp. Allergy 2006; 36: 1602–8.
42. Ouwehand AC, Isolauri E, He F et al. Differences in Bifidobacterium flora composition in allergic and healthy infants. J. Allergy Clin. Immunol. 2001; 108: 144–5.
43. He F, Morita H, Hashimoto H et al. Intestinal Bifidobacterium species induce varying cytokine production. J. Allergy Clin. Immunol. 2002; 109: 1035–6.
44. Sanders ME. Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 2008; 46(Suppl. 2): S58–61.; discussion S144–51.
45. Kalliomaki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076–9.
46. Kalliomaki M, Salminen S, Poussa T et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869–71.
47. Isolauri E, Arvola T, Sutas Y et al. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000; 30: 1604–10.
48. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J et al. Probiotics for treating eczema. Cochrane Database Syst. Rev. 2008; : CD006135.
49. Kirjavainen PV, Gibson GR. Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann. Med. 1999; 31: 288–92.
50. Prescott SL, Macaubas C, Holt BJ et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol. 1998; 160: 4730–7.
51. Mazmanian SK, Liu CH, Tzianabos AO et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107–18.
52. Charlson ES, Bittinger K, Haas AR et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 2011; 184: 957–63.
53. Hilty M, Burke C, Pedro H et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5: e8578.
54. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin. Infect. Dis. 2003; 36: 580–5.